Impact of Atopic Dermatitis on Adult Women’s Lives: A Survey of 1,009 French Women
DOI:
https://doi.org/10.2340/actadv.v104.10321Keywords:
atopic dermatitis, women, Quality of Life, sleepAbstract
Atopic dermatitis (AD) is one of the most common inflammatory diseases, and has a higher prevalence among females in adulthood. The aim of this observational, cross-sectional, survey-based study was to evaluate the impact of AD on the daily lives of adult women patients. A scientific committee composed exclusively of women constructed a specific questionnaire in partnership with the French Eczema Association. Severity of AD was evaluated with the Patient-Oriented Eczema Measure (POEM). A sample of 1,009 adult women (mean age ± standard deviation: 41.8 ± 14.2 years) with AD was identified from a representative sample of the French population (82% response rate 1,230 women surveyed). According to the POEM, 50.64% (n = 511) of subjects were identified as having mild AD, 39.35% (n = 397) moderate AD, and 10.01% (n = 101) severe AD. Overall, 67.7% (n = 682) reported that their eczema involved a visible area (face, neck or hands), and 19.6% (n = 198) a sensual area (breasts/chest, genital area or buttocks). Of the 720 women with menstrual cycles, exacerbations of AD were reported to occur mostly before (50.6%) and during (48.3%) menstruation. A small proportion of women, 7.3% (n = 74), reported being afraid of becoming pregnant because of their eczema. If AD involvement was in a visible area it had a greater impact on romantic relationships, sexual relationships and occupation. If AD involvement was in a sensual area it had a greater influence on romantic relationships and sexuality. Particular attention should be given to patients with localization of AD on the face, neck or hands, as they have a higher risk of social exclusion. Moreover, these results should encourage health professionals to ask patients with AD about the possible involvement of sensual areas.
Downloads
References
Bylund S, Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol 2020; 100: adv00160.
https://doi.org/10.2340/00015555-3510 DOI: https://doi.org/10.2340/00015555-3510
Mohn CH, Blix HS, Halvorsen JA, Nafstad P, Valberg M, Lagerløv P. Incidence trends of atopic dermatitis in infancy and early childhood in a nationwide prescription registry study in Norway. JAMA Netw Open 2018; 1:e184145.
https://doi.org/10.1001/jamanetworkopen.2018.4145 DOI: https://doi.org/10.1001/jamanetworkopen.2018.4145
Johansson EK, Bergström A, Kull I, Melén E, Jonsson M, Lundin S, et al. Prevalence and characteristics of atopic dermatitis among young adult females and males-report from the Swedish population-based study BAMSE. J Eur Acad Dermatol Venereol 2022; 36: 698-704.
https://doi.org/10.1111/jdv.17929 DOI: https://doi.org/10.1111/jdv.17929
Richard MA, Paul C, Nijsten T, Gisondi P, Salvalastru C, Taieb C, et al. Prevalence of most common skin diseases in Europe: a population-based study. J Eur Acad Dermatol Venereol 2022; 36: 1088-1096.
https://doi.org/10.1111/jdv.18050 DOI: https://doi.org/10.1111/jdv.18050
Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol 2014; 150: 593-600.
https://doi.org/10.1001/jamadermatol.2013.10271 DOI: https://doi.org/10.1001/jamadermatol.2013.10271
Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 2018; 73: 696-704.
https://doi.org/10.1111/all.13320 DOI: https://doi.org/10.1111/all.13320
Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol 2013; 132: 1132-1128.
https://doi.org/10.1016/j.jaci.2013.08.031 DOI: https://doi.org/10.1016/j.jaci.2013.08.031
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol 2018; 121: 340-347.
https://doi.org/10.1016/j.anai.2018.07.006 DOI: https://doi.org/10.1016/j.anai.2018.07.006
Eckert L, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM. Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey. J Am Acad Dermatol 2017; 77: 274-279.e3.
https://doi.org/10.1016/j.jaad.2017.04.019 DOI: https://doi.org/10.1016/j.jaad.2017.04.019
Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM, et al.The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017. Br J Dermatol 2021; 184: 304-309.
https://doi.org/10.1111/bjd.19580 DOI: https://doi.org/10.1111/bjd.19580
Birdi G, Larkin M, Knibb RC. Prospective analysis of the temporal relationship between psychological distress and atopic dermatitis in female adults: a preliminary study. Healthc Basel Switz 2022; 10: 1913.
https://doi.org/10.3390/healthcare10101913 DOI: https://doi.org/10.3390/healthcare10101913
Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol 2017; 137: 26-30.
https://doi.org/10.1016/j.jid.2016.07.012 DOI: https://doi.org/10.1016/j.jid.2016.07.012
Ali F, Vyas J, Finlay AY. Counting the burden: atopic dermatitis and health-related quality of life. Acta Derm Venereol 2020; 100: adv00161.
https://doi.org/10.2340/00015555-3511 DOI: https://doi.org/10.2340/00015555-3511
Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004; 140: 1513-1519.
https://doi.org/10.1001/archderm.140.12.1513 DOI: https://doi.org/10.1001/archderm.140.12.1513
Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol 2013; 169: 1326-1332.
https://doi.org/10.1111/bjd.12590 DOI: https://doi.org/10.1111/bjd.12590
Creadore A, Manjaly P, Li SJ, Tkachenko E, Zhou G, Joyce C, et al. Evaluation of stigma toward individuals with alopecia. JAMA Dermatol 2021; 157: 392-398.
https://doi.org/10.1001/jamadermatol.2020.5732 DOI: https://doi.org/10.1001/jamadermatol.2020.5732
Pearl RL, Wan MT, Takeshita J, Gelfand JM. Stigmatizing attitudes toward persons with psoriasis among laypersons and medical students. J Am Acad Dermatol 2019; 80: 1556-1563.
https://doi.org/10.1016/j.jaad.2018.08.014 DOI: https://doi.org/10.1016/j.jaad.2018.08.014
Misery L, Finlay AY, Martin N, Boussetta S, Nguyen C, Myon E, et al. Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatol Basel Switz 2007; 215: 123-129.
https://doi.org/10.1159/000104263 DOI: https://doi.org/10.1159/000104263
Holm EA, Esmann S, Jemec GBE. Does visible atopic dermatitis affect quality of life more in women than in men? Gend Med 2004; 1:125-30.
https://doi.org/10.1016/S1550-8579(04)80017-2 DOI: https://doi.org/10.1016/S1550-8579(04)80017-2
Augustin M, Misery L, von Kobyletzski L, Mealing S, Redding M, Chuang CC, et al. Systematic literature review assessing the overall costs and societal impacts of moderate-to-severe atopic dermatitis in Europe. J Eur Acad Dermatol Venereol 2022; 36: 2316-2324.
https://doi.org/10.1111/jdv.18481 DOI: https://doi.org/10.1111/jdv.18481
Stingeni L, Belloni Fortina A, Baiardini I, Hansel K, Moretti D, Cipriani F. Atopic dermatitis and patient perspectives: insights of bullying at school and career discrimination at work. J Asthma Allergy 2021; 14: 919-928.
https://doi.org/10.2147/JAA.S317009 DOI: https://doi.org/10.2147/JAA.S317009
Tableaux de l'économie française édition 2020. Insee. (n.d.). [Accessed 2022 November 17]. Available from: https://www.insee.fr/fr/statistiques/4277649?sommaire = 4318291
Linares-Gonzalez L, Lozano-Lozano I, Gutierrez-Rojas L, Lozano-Lozano M, Rodenas-Herranz T, Ruiz-Villaverde R. Sexual dysfunction and atopic dermatitis: a systematic review. Life Basel Switz 2021; 11: 1314.
https://doi.org/10.3390/life11121314 DOI: https://doi.org/10.3390/life11121314
Linares-Gonzalez L, Lozano-Lozano I, Gutierrez-Rojas L, Ruiz-Villaverde R, Lozano-Lozano M. Sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis. Influence of dupilumab treatment. Int J Dermatol 2022; 61: 607-610.
https://doi.org/10.1111/ijd.15938 DOI: https://doi.org/10.1111/ijd.15938
Ludwig CM, Fernandez JM, Hsiao JL, Shi VY. The interplay of atopic dermatitis and sexual health. Dermatitis 2020; 31: 303-308.
https://doi.org/10.1097/DER.0000000000000617 DOI: https://doi.org/10.1097/DER.0000000000000617
Kemmett D, Tidman MJ. The influence of the menstrual cycle and pregnancy on atopic dermatitis. Br J Dermatol 1991; 125: 59-61.
https://doi.org/10.1111/j.1365-2133.1991.tb06041.x DOI: https://doi.org/10.1111/j.1365-2133.1991.tb06041.x
Maccari F, Fougerousse AC, Reguiai Z, Taieb C. Contraception, sexuality and pregnancy in women with psoriasis: real-life experience of 235 women. Clin Cosmet Investig Dermatol 2020; 13: 817-23.
https://doi.org/10.2147/CCID.S275512 DOI: https://doi.org/10.2147/CCID.S275512
Cho S, Kim HJ, Oh SH, Park CO, Jung JY, Lee KH. The influence of pregnancy and menstruation on the deterioration of atopic dermatitis symptoms. Ann Dermatol 2010; 22: 180-185.
https://doi.org/10.5021/ad.2010.22.2.180 DOI: https://doi.org/10.5021/ad.2010.22.2.180
Rakita U, Kaundinya T, Silverberg JI. Lack of association between atopic dermatitis severity and worsening during pregnancy: a cross-sectional study. J Am Acad Dermatol 2022; 86: 438-40.
https://doi.org/10.1016/j.jaad.2021.09.066 DOI: https://doi.org/10.1016/j.jaad.2021.09.066
Alcantara-Luna S, Ruiz-Villaverde R, Domínguez-Cruz J, et al. Validation of a questionnaire to assess the perception of women with atopic dermatitis in family planning. Int J Environ Res Public Health 2022; 19: 10753.
https://doi.org/10.3390/ijerph191710753 DOI: https://doi.org/10.3390/ijerph191710753
Rakita U, Kaundinya T, Silverberg JI. Association of atopic dermatitis severity with menstrual worsening of disease in women: a cross-sectional study. J Eur Acad Dermatol Venereol 2022; 36: e197-e199.
https://doi.org/10.1111/jdv.17730 DOI: https://doi.org/10.1111/jdv.17730
Kiriyama K, Sugiura H, Uehara M. Premenstrual deterioration of skin symptoms in female patients with atopic dermatitis. Dermatol Basel Switz 2003; 206: 110-102.
https://doi.org/10.1159/000068463 DOI: https://doi.org/10.1159/000068463
Bello GD, Maurelli M, Schena D, Gisondi P, Girolomoni G. Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle. J Am Acad Dermatol 2022; 87: 892-895.
https://doi.org/10.1016/j.jaad.2021.12.014 DOI: https://doi.org/10.1016/j.jaad.2021.12.014
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anne Claire Fougerousse, Marina Alexandre, Anne Sophie Darrigade, Stéphanie Merhand, Adrien Marquié, Medhi Hamza, Gaelle Le Fur, Marie Jachiet, Anne Claire Bursztejn, Charles Taieb
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
